Krzystanek, M.; Warchala, A.; Trędzbor, B.; Martyniak, E.; Skałacka, K.; Pałasz, A.
Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics—The Pilot Case Series Study. Pharmaceuticals 2021, 14, 947.
https://doi.org/10.3390/ph14100947
AMA Style
Krzystanek M, Warchala A, Trędzbor B, Martyniak E, Skałacka K, Pałasz A.
Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics—The Pilot Case Series Study. Pharmaceuticals. 2021; 14(10):947.
https://doi.org/10.3390/ph14100947
Chicago/Turabian Style
Krzystanek, Marek, Anna Warchala, Beata Trędzbor, Ewa Martyniak, Katarzyna Skałacka, and Artur Pałasz.
2021. "Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics—The Pilot Case Series Study" Pharmaceuticals 14, no. 10: 947.
https://doi.org/10.3390/ph14100947
APA Style
Krzystanek, M., Warchala, A., Trędzbor, B., Martyniak, E., Skałacka, K., & Pałasz, A.
(2021). Amantadine in the Treatment of Sexual Inactivity in Schizophrenia Patients Taking Atypical Antipsychotics—The Pilot Case Series Study. Pharmaceuticals, 14(10), 947.
https://doi.org/10.3390/ph14100947